Email already exists. Please login.
Home Agtech
agtech
Australian start-up reveals AI-powered farm valuation platform
Agtech start-up Digital Agriculture Services recently secured funding from CSIRO and has seen strong interest from investors in using its web-based platform.
Aqua backs Brazil biologicals company with $30m
Managing partner Sebastian Popik tells Agri Investor that intense competition in Brazil’s biologicals market inspired the firm to build their own company before buying a stake in Total Biotechnologia.
Agtech investment focus shifts towards science as market scales
Describing the firm’s recent Agtech Investment Review, Finistere Ventures' Arama Kukutai tells Agri Investor he expects private equity investors to acquire leading start-ups and pursue roll-ups as the market continues to develop.
Outlook 2019: Five trends to watch
We asked Axel Wehr, principal at specialist ag/food tech VC Anterra Capital, to share his top predictions for 2019.
Investors back InspiraFarms research to cut harvest losses in developing countries
The firm’s project features the installation of energy-efficient, small-scale refrigerated storage near the point of harvest to cut losses and drive investment across Africa, India and Latin America.
Australian agtech lagging other countries but outlook is ‘positive’
A new report has found Australia invested $0.12 per capita in agtech in 2016, far behind $5.80 in the US and $6.05 in Israel.
VIDEO: When horticulture meets aquaculture
Green Camel, in Sydney’s south-west, is raising A$8.5m as it pioneers organic glasshouse farming collocated with barramundi breeding on a commercial scale. Agri Investor got an exclusive tour of the facilities.
Waving goodbye
In his last Weekly Letter as editor of Agri Investor, Matthieu Favas argues that agriculture today is changing at a much faster pace than many observers often think.
Bill Gates-led VC and Singapore SWF bet on alternative fertilizers
Pivot Bio chief executive Karsten Temme says the nitrogen-producing microbe business, which just closed a $70m Series B, could help upend a market worth about $200bn.
Salveo backs cannabis biotech in $10m Series A
Managing partner Jeffrey Howard says Front Range Biosciences is among the companies benefiting from a surge in private investor interest in cannabis.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please email: customerservices@peimedia.com.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please email: customerservices@peimedia.com.